Kapromorelin (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kapromorelin" in Serbian language version.

refsWebsite

Global rank Serbian rank

5nih.gov

4^th place

8^th place

4doi.org

2^nd place

4^th place

2semanticscholar.org

11^th place

23^rd place

doi.org

Khojasteh-Bakht, S. C.; O'Donnell, J. P.; Fouda, H. G.; Potchoiba, M. J. (2005). „Metabolism, pharmacokinetics, tissue distribution, and excretion of 14CCP-424391 in rats”. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 15486077 (1): 190—199. PMID 15486077. S2CID 20760627. doi:10.1124/dmd.104.001065.
Carpino, P. A.; Lefker, B. A.; Toler, S. M.; Pan, L. C.; Hadcock, J. R.; Murray, M. C.; Cook, E. R.; Dibrino, J. N.; Deninno, S. L.; Chidsey-Frink, K. L.; Hada, W. A.; Inthavongsay, J.; Lewis, S. K.; Mangano, F. M.; Mullins, M. A.; Nickerson, D. F.; Ng, O.; Pirie, C. M.; Ragan, J. A.; Rose, C. R.; Tess, D. A.; Wright, A. S.; Yu, L.; Zawistoski, M. P.; Pettersen, J. C.; Dasilva-Jardine, P. A.; Wilson, T. C.; Thompson, D. D. (2002). „Discovery and biological characterization of capromorelin analogues with extended half-lives”. Bioorganic & Medicinal Chemistry Letters. 12392732 (22): 3279—3282. PMID 12392732. doi:10.1016/s0960-894x(02)00734-5.
Carpino, P. A.; Lefker, B. A.; Toler, S. M.; Pan, L. C.; Hadcock, J. R.; Cook, E. R.; Dibrino, J. N.; Campeta, A. M.; Deninno, S. L.; Chidsey-Frink, K. L.; Hada, W. A.; Inthavongsay, J.; Mangano, F. M.; Mullins, M. A.; Nickerson, D. F.; Ng, O.; Pirie, C. M.; Ragan, J. A.; Rose, C. R.; Tess, D. A.; Wright, A. S.; Yu, L.; Zawistoski, M. P.; Dasilva-Jardine, P. A.; Wilson, T. C.; Thompson, D. D. (2003). „Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSS). Discovery of capromorelin”. Bioorganic & Medicinal Chemistry. 12538023 (4): 581—590. PMID 12538023. doi:10.1016/s0968-0896(02)00433-9.
Pan, L. C.; Carpino, P. A.; Lefker, B. A.; Ragan, J. A.; Toler, S. M.; Pettersen, J. C.; Nettleton, D. O.; Ng, O.; Pirie, C. M.; Chidsey-Frink, K.; Lu, B.; Nickerson, D. F.; Tess, D. A.; Mullins, M. A.; MacLean, D. B.; Dasilva-Jardine, P. A.; Thompson, D. D. (2001). „Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine correction of pyrazolidinone-piperidine growth hormone secretagogue”. Endocrine. 11322494 (1): 121—132. PMID 11322494. S2CID 46978604. doi:10.1385/endo:14:1:121.

nih.gov

ncbi.nlm.nih.gov

Khojasteh-Bakht, S. C.; O'Donnell, J. P.; Fouda, H. G.; Potchoiba, M. J. (2005). „Metabolism, pharmacokinetics, tissue distribution, and excretion of 14CCP-424391 in rats”. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 15486077 (1): 190—199. PMID 15486077. S2CID 20760627. doi:10.1124/dmd.104.001065.
Carpino, P. A.; Lefker, B. A.; Toler, S. M.; Pan, L. C.; Hadcock, J. R.; Murray, M. C.; Cook, E. R.; Dibrino, J. N.; Deninno, S. L.; Chidsey-Frink, K. L.; Hada, W. A.; Inthavongsay, J.; Lewis, S. K.; Mangano, F. M.; Mullins, M. A.; Nickerson, D. F.; Ng, O.; Pirie, C. M.; Ragan, J. A.; Rose, C. R.; Tess, D. A.; Wright, A. S.; Yu, L.; Zawistoski, M. P.; Pettersen, J. C.; Dasilva-Jardine, P. A.; Wilson, T. C.; Thompson, D. D. (2002). „Discovery and biological characterization of capromorelin analogues with extended half-lives”. Bioorganic & Medicinal Chemistry Letters. 12392732 (22): 3279—3282. PMID 12392732. doi:10.1016/s0960-894x(02)00734-5.
Carpino, P. A.; Lefker, B. A.; Toler, S. M.; Pan, L. C.; Hadcock, J. R.; Cook, E. R.; Dibrino, J. N.; Campeta, A. M.; Deninno, S. L.; Chidsey-Frink, K. L.; Hada, W. A.; Inthavongsay, J.; Mangano, F. M.; Mullins, M. A.; Nickerson, D. F.; Ng, O.; Pirie, C. M.; Ragan, J. A.; Rose, C. R.; Tess, D. A.; Wright, A. S.; Yu, L.; Zawistoski, M. P.; Dasilva-Jardine, P. A.; Wilson, T. C.; Thompson, D. D. (2003). „Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSS). Discovery of capromorelin”. Bioorganic & Medicinal Chemistry. 12538023 (4): 581—590. PMID 12538023. doi:10.1016/s0968-0896(02)00433-9.
Pan, L. C.; Carpino, P. A.; Lefker, B. A.; Ragan, J. A.; Toler, S. M.; Pettersen, J. C.; Nettleton, D. O.; Ng, O.; Pirie, C. M.; Chidsey-Frink, K.; Lu, B.; Nickerson, D. F.; Tess, D. A.; Mullins, M. A.; MacLean, D. B.; Dasilva-Jardine, P. A.; Thompson, D. D. (2001). „Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine correction of pyrazolidinone-piperidine growth hormone secretagogue”. Endocrine. 11322494 (1): 121—132. PMID 11322494. S2CID 46978604. doi:10.1385/endo:14:1:121.
Thompson, D. D. (2007). „Aging and sarcopenia”. Journal of Musculoskeletal & Neuronal Interactions. 18094505 (4): 344—345. PMID 18094505.

semanticscholar.org

api.semanticscholar.org

Khojasteh-Bakht, S. C.; O'Donnell, J. P.; Fouda, H. G.; Potchoiba, M. J. (2005). „Metabolism, pharmacokinetics, tissue distribution, and excretion of 14CCP-424391 in rats”. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 15486077 (1): 190—199. PMID 15486077. S2CID 20760627. doi:10.1124/dmd.104.001065.
Pan, L. C.; Carpino, P. A.; Lefker, B. A.; Ragan, J. A.; Toler, S. M.; Pettersen, J. C.; Nettleton, D. O.; Ng, O.; Pirie, C. M.; Chidsey-Frink, K.; Lu, B.; Nickerson, D. F.; Tess, D. A.; Mullins, M. A.; MacLean, D. B.; Dasilva-Jardine, P. A.; Thompson, D. D. (2001). „Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine correction of pyrazolidinone-piperidine growth hormone secretagogue”. Endocrine. 11322494 (1): 121—132. PMID 11322494. S2CID 46978604. doi:10.1385/endo:14:1:121.